<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-title>Critical Care</journal-title><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11056699</article-id><article-id pub-id-type="pmc">28991</article-id><article-id pub-id-type="publisher-id">cc-1-2-075</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>A comparison of volume control and pressure-regulated volume control ventilation in acute respiratory failure</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Guldager</surname><given-names>Henrik</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>Henrik.Guldager@Apple.Agora.dk</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Nielsen</surname><given-names>Soeren L</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A3" contrib-type="author"><name><surname>Carl</surname><given-names>Peder</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib id="A4" contrib-type="author"><name><surname>Soerensen</surname><given-names>Mogens B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Department of Anaesthesia and Intensive Care, Hvidovre University Hospital, DK-2650 Hvidovre, Denmark.</aff><aff id="I2"><label>2</label>Department of Anaesthesia and Intensive Care, Slagelse Central Hospital, DK-4200 Slagelse, Denmark.</aff><pub-date pub-type="ppub"><year>1997</year></pub-date><pub-date pub-type="epub"><day>26</day><month>11</month><year>1997</year></pub-date><volume>1</volume><issue>2</issue><fpage>75</fpage><lpage>77</lpage><history><date date-type="received"><day>4</day><month>6</month><year>1997</year></date><date date-type="rev-request"><day>3</day><month>9</month><year>1997</year></date><date date-type="rev-recd"><day>13</day><month>10</month><year>1997</year></date><date date-type="accepted"><day>15</day><month>10</month><year>1997</year></date></history><copyright-statement>Copyright © 1997 Current Science Ltd</copyright-statement><abstract><sec><title><offsets xml_i="2509" xml_f="2520" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="2531" xml_f="3308" txt_i="23" txt_f="797">The aim of this study was to test the hypothesis that a new mode of ventilation (pressure-regulated volume control; PRVC) is associated with improvements in respiratory mechanics and outcome when compared with conventional volume control (VC) ventilation in patients with acute respiratory failure. We conducted a randomised, prospective, open, cross over trial on 44 patients with acute respiratory failure in the general intensive care unit of a university hospital. After a stabilization period of 8 h, a cross over trial of 2 × 2 h was conducted. Apart from the PRVC/VC mode, ventilator settings were comparable. The following parameters were recorded for each patient: days on ventilator, failure in the assigned mode of ventilation (peak inspiratory pressure  &gt; 50 cmH</offsets><sub><offsets xml_i="3313" xml_f="3314" txt_i="797" txt_f="798">2</offsets></sub><offsets xml_i="3320" xml_f="3336" txt_i="798" txt_f="814">O) and survival.</offsets></p></sec><sec><title><offsets xml_i="3358" xml_f="3366" txt_i="816" txt_f="824">Results:</offsets></title><p><offsets xml_i="3377" xml_f="3482" txt_i="825" txt_f="930">In the crossover trial, peak inspiratory pressure was significantly lower using PRVC than with VC (20 cmH</offsets><sub><offsets xml_i="3487" xml_f="3488" txt_i="930" txt_f="931">2</offsets></sub><offsets xml_i="3494" xml_f="3496" txt_i="931" txt_f="933">O </offsets><italic><offsets xml_i="3504" xml_f="3506" txt_i="933" txt_f="935">vs</offsets></italic><offsets xml_i="3515" xml_f="3522" txt_i="935" txt_f="942"> 24 cmH</offsets><sub><offsets xml_i="3527" xml_f="3528" txt_i="942" txt_f="943">2</offsets></sub><offsets xml_i="3534" xml_f="3537" txt_i="943" txt_f="946">O, </offsets><italic><offsets xml_i="3545" xml_f="3546" txt_i="946" txt_f="947">P</offsets></italic><offsets xml_i="3555" xml_f="3628" txt_i="947" txt_f="1017"> &lt; 0.0001). No other statistically significant differences were found.</offsets></p></sec><sec><title><offsets xml_i="3650" xml_f="3662" txt_i="1019" txt_f="1031">Conclusions:</offsets></title><p><offsets xml_i="3673" xml_f="3926" txt_i="1032" txt_f="1285">Peak inspiratory pressure was significantly lower during PRVC ventilation than during VC ventilation, and thus PRVC may be superior to VC in certain patients. However, in this small group of patients, we could not demonstrate that PRVC improved outcome.</offsets></p></sec></abstract><kwd-group><kwd>intensive care</kwd><kwd>mechanical ventilation</kwd><kwd>respiratory failure</kwd></kwd-group></article-meta></front><body><sec><title><offsets xml_i="4099" xml_f="4111" txt_i="1294" txt_f="1306">Introduction</offsets></title><p><offsets xml_i="4122" xml_f="4251" txt_i="1307" txt_f="1436">During mechanical ventilation, the application of positive pressure with a peak inspiratory pressure (PIP) in excess of 50–60 cmH</offsets><sub><offsets xml_i="4256" xml_f="4257" txt_i="1436" txt_f="1437">2</offsets></sub><offsets xml_i="4263" xml_f="4293" txt_i="1437" txt_f="1467">O may result in a barotrauma [</offsets><xref ref-type="bibr" rid="B1"><offsets xml_i="4324" xml_f="4325" txt_i="1467" txt_f="1468">1</offsets></xref><offsets xml_i="4332" xml_f="4465" txt_i="1468" txt_f="1601">]. Gross overinflation leads to rupture of the airways which may result in pneumothorax, pneumomediastinum or subcutaneous emphysema.</offsets></p><p><offsets xml_i="4472" xml_f="4545" txt_i="1602" txt_f="1675">Animal experiments have established that even PIP at a level of 30–40 cmH</offsets><sub><offsets xml_i="4550" xml_f="4551" txt_i="1675" txt_f="1676">2</offsets></sub><offsets xml_i="4557" xml_f="4778" txt_i="1676" txt_f="1897">O results in lung overinflation and may cause pulmonary interstitial edema, inflammation and elevated vascular permeability, a picture that resembles acute respiratory distress syndrome (ARDS) or acute lung injury (ALI) [</offsets><xref ref-type="bibr" rid="B2"><offsets xml_i="4809" xml_f="4810" txt_i="1897" txt_f="1898">2</offsets></xref><offsets xml_i="4817" xml_f="4818" txt_i="1898" txt_f="1899">,</offsets><xref ref-type="bibr" rid="B3"><offsets xml_i="4849" xml_f="4850" txt_i="1899" txt_f="1900">3</offsets></xref><offsets xml_i="4857" xml_f="4858" txt_i="1900" txt_f="1901">,</offsets><xref ref-type="bibr" rid="B4"><offsets xml_i="4889" xml_f="4890" txt_i="1901" txt_f="1902">4</offsets></xref><offsets xml_i="4897" xml_f="4898" txt_i="1902" txt_f="1903">,</offsets><xref ref-type="bibr" rid="B5"><offsets xml_i="4929" xml_f="4930" txt_i="1903" txt_f="1904">5</offsets></xref><offsets xml_i="4937" xml_f="5188" txt_i="1904" txt_f="2155">]. The pulmonary injury is often distributed quite heterogeneously. This means that normally functioning parts of the lung are scattered between parts that are diseased, either as totally consolidated lung or as collapsed potentially expandable lung [</offsets><xref ref-type="bibr" rid="B6"><offsets xml_i="5219" xml_f="5220" txt_i="2155" txt_f="2156">6</offsets></xref><offsets xml_i="5227" xml_f="5229" txt_i="2156" txt_f="2158">].</offsets></p><p><offsets xml_i="5236" xml_f="5569" txt_i="2159" txt_f="2492">Conventional ventilation may lead to overdistention of the normally functioning lung while expanding collapsed parts. Thus, mechanical ventilation may exacerbate the pulmonary pathology and/or delay recovery. In two studies of patients with ARDS, it was concluded that survival is better when high ventilation pressures are avoided [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="5600" xml_f="5601" txt_i="2492" txt_f="2493">7</offsets></xref><offsets xml_i="5608" xml_f="5609" txt_i="2493" txt_f="2494">,</offsets><xref ref-type="bibr" rid="B8"><offsets xml_i="5640" xml_f="5641" txt_i="2494" txt_f="2495">8</offsets></xref><offsets xml_i="5648" xml_f="5739" txt_i="2495" txt_f="2586">]. There have been no such studies in patients with acute respiratory failure without ARDS.</offsets></p><p><offsets xml_i="5746" xml_f="5968" txt_i="2587" txt_f="2809">Pressure-regulated volume control (PRVC) is a new mode of ventilation that combines the advantages of the decelerating inspiratory flow pattern of a pressure-control mode with the ease of use of a volume-control (VC) mode.</offsets></p><p><offsets xml_i="5975" xml_f="6183" txt_i="2810" txt_f="3018">The aim of this study was to test the hypothesis that PRVC associated with improvements in respiratory mechanics, outcome and length of intensive care unit stay when compared with conventional VC ventilation.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="6234" xml_f="6255" txt_i="3020" txt_f="3041">Materials and methods</offsets></title><p><offsets xml_i="6266" xml_f="6498" txt_i="3042" txt_f="3274">The study was approved by the ethics committee of Copenhagen (reg no 01-182/93) and was conducted in accordance with the Helsinki declaration. Data were collected prospectively, and randomization was achieved using scaled envelopes.</offsets></p><p><offsets xml_i="6505" xml_f="6602" txt_i="3275" txt_f="3372">The inclusion criteria were acute respiratory failure, a partial pressure of arterial oxygen (PaO</offsets><sub><offsets xml_i="6607" xml_f="6608" txt_i="3372" txt_f="3373">2</offsets></sub><offsets xml_i="6614" xml_f="6625" txt_i="3373" txt_f="3384">; mmHg)/FiO</offsets><sub><offsets xml_i="6630" xml_f="6631" txt_i="3384" txt_f="3385">2</offsets></sub><offsets xml_i="6637" xml_f="6677" txt_i="3385" txt_f="3422"> ratio of  &lt; 300 with a PEEP of 5 cmH</offsets><sub><offsets xml_i="6682" xml_f="6683" txt_i="3422" txt_f="3423">2</offsets></sub><offsets xml_i="6689" xml_f="6695" txt_i="3423" txt_f="3429">O, FiO</offsets><sub><offsets xml_i="6700" xml_f="6701" txt_i="3429" txt_f="3430">2</offsets></sub><offsets xml_i="6707" xml_f="6877" txt_i="3430" txt_f="3600"> between 0.4 and 0.6, and age 18 years or more. Patients with an expected ventilator therapy of less than 24 h were excluded as were patients with intracranial pathology.</offsets></p><p><offsets xml_i="6884" xml_f="7174" txt_i="3601" txt_f="3891">After an initial stabilization period (up to 8 h) the patients were randomized to PRVC or VC. The following variables were instituted for both groups during ventilation: tidal volume (VT) 5–8 ml/kg, a respiratory rate to achieve the desired partial pressure of arterial carbon dioxide (PaCO</offsets><sub><offsets xml_i="7179" xml_f="7180" txt_i="3891" txt_f="3892">2</offsets></sub><offsets xml_i="7186" xml_f="7781" txt_i="3892" txt_f="4487">), inspiratory time 30% (no pause) and constant PEEP. After a period of 2 h, the patients were switched to the alternative method of ventilation (PRVC or VC) for a further 2 h without any other ventilatory changes. After measurement, the patients were returned to the mode of ventilation initially assigned. The patients assigned to PRVC were weaned on volume support and the patients assigned to VC were weaned on pressure support. To ensure that the two groups of patients received the same kind of ventilator management a protocol was used (which can be obtained from the authors on request).</offsets></p><p><offsets xml_i="7788" xml_f="7958" txt_i="4488" txt_f="4658">All patients were ventilated using a Siemens Servo 300 ventilator (Siemens Elema AB, Solna, Sweden). The following variables were measured: PIP, mean airway pressure, PaO</offsets><sub><offsets xml_i="7963" xml_f="7964" txt_i="4658" txt_f="4659">2</offsets></sub><offsets xml_i="7970" xml_f="7976" txt_i="4659" txt_f="4665">, PaCO</offsets><sub><offsets xml_i="7981" xml_f="7982" txt_i="4665" txt_f="4666">2</offsets></sub><offsets xml_i="7988" xml_f="8126" txt_i="4666" txt_f="4801">, pH and mean arterial pressure (MAP). The number of days on the ventilator, failure of the assigned mode of ventilation (PIP  &gt; 50 cmH</offsets><sub><offsets xml_i="8131" xml_f="8132" txt_i="4801" txt_f="4802">2</offsets></sub><offsets xml_i="8138" xml_f="8173" txt_i="4802" txt_f="4837">O) and survival were also recorded.</offsets></p><p><offsets xml_i="8180" xml_f="8369" txt_i="4838" txt_f="5027">Airway pressures were recorded on the display monitor of the ventilator and arterial blood gases were measured using an arterial blood gas analyser (ABL 2; Radiometer, Copenhagen, Denmark).</offsets></p><sec><title><offsets xml_i="8385" xml_f="8405" txt_i="5028" txt_f="5048">Statistical analysis</offsets></title><p><offsets xml_i="8416" xml_f="8608" txt_i="5049" txt_f="5241">For categorical data, Fisher's exact test was used. For numerical data, non-parametric tests were used: the Wilcoxon test in the crossover trial and the Mann–Whitney test in the general trial.</offsets></p></sec></sec><sec><title><offsets xml_i="8636" xml_f="8643" txt_i="5244" txt_f="5251">Results</offsets></title><p><offsets xml_i="8654" xml_f="8764" txt_i="5252" txt_f="5362">Forty-Four patients with acute respiratory failure were included. No patient was excluded after randomization.</offsets></p><p><offsets xml_i="8771" xml_f="9145" txt_i="5363" txt_f="5737">There were no statistically significant differences between demographic data for the two groups: median age 57 years (95% confidence interval 52–66) and 60 years (95% confidence interval 55–70), an APACHE II score of 18 (95% confidence interval 16–22) and 16 (95% confidence interval 14–19) and a male/female ratio of 16/6 and 10/12 for the PRVC and VC groups, respectively.</offsets></p><p><offsets xml_i="9152" xml_f="9206" txt_i="5738" txt_f="5792">The results of the crossover study are shown in Table </offsets><xref ref-type="table" rid="T1"><offsets xml_i="9238" xml_f="9239" txt_i="5792" txt_f="5793">1</offsets></xref><offsets xml_i="9246" xml_f="9421" txt_i="5793" txt_f="5968">, where the number of patients in each group is given as 44 because every patient was crossed over (paired comparison). There was a significantly lower PIP in the PRVC group (</offsets><italic><offsets xml_i="9429" xml_f="9430" txt_i="5968" txt_f="5969">P</offsets></italic><offsets xml_i="9439" xml_f="9454" txt_i="5969" txt_f="5981">  &lt; 0.0001).</offsets></p><p><offsets xml_i="9461" xml_f="9513" txt_i="5982" txt_f="6034">The results of the general trial are shown in Table </offsets><xref ref-type="table" rid="T2"><offsets xml_i="9545" xml_f="9546" txt_i="6034" txt_f="6035">2</offsets></xref><offsets xml_i="9553" xml_f="9643" txt_i="6035" txt_f="6122">. Two patients in the VC group failed the assigned mode of ventilation of PIP  &gt; 50 cmH</offsets><sub><offsets xml_i="9648" xml_f="9649" txt_i="6122" txt_f="6123">2</offsets></sub><offsets xml_i="9655" xml_f="9657" txt_i="6123" txt_f="6125">O.</offsets></p></sec><sec><title><offsets xml_i="9679" xml_f="9689" txt_i="6127" txt_f="6137">Discussion</offsets></title><p><offsets xml_i="9700" xml_f="9952" txt_i="6138" txt_f="6390">This study shows the advantage of using the PRVC mode for ventilation during acute respiratory failure. PIP was lower for all patients using the PRVC mode compared to the VC mode, and alveolar ventilation was unchanged as indicated by the constant PaCO</offsets><sub><offsets xml_i="9957" xml_f="9958" txt_i="6390" txt_f="6391">2</offsets></sub><offsets xml_i="9964" xml_f="10115" txt_i="6391" txt_f="6542">. The new mode of ventilation did not improve outcome or duration of treatment, despite a statistically significant difference in peak pressures (4 cmH</offsets><sub><offsets xml_i="10120" xml_f="10121" txt_i="6542" txt_f="6543">2</offsets></sub><offsets xml_i="10127" xml_f="10263" txt_i="6543" txt_f="6679">O). Though this difference in peak pressure is small, it may be more relevant in situations where larger tidal volumes are contemplated.</offsets></p><p><offsets xml_i="10270" xml_f="10575" txt_i="6680" txt_f="6985">This study is the only study that has measured the difference between PIP on the two modes of ventilation, PRVC and VC. In contrast to other studies comparing pressure-limited ventilation with various forms of ventilation, our patients had only mild respiratory insufficiency. In the studies by Rappaport </offsets><italic><offsets xml_i="10583" xml_f="10588" txt_i="6985" txt_f="6990">et al</offsets></italic><offsets xml_i="10597" xml_f="10599" txt_i="6990" txt_f="6992"> [</offsets><xref ref-type="bibr" rid="B9"><offsets xml_i="10630" xml_f="10631" txt_i="6992" txt_f="6993">9</offsets></xref><offsets xml_i="10638" xml_f="10653" txt_i="6993" txt_f="7008">] and Hickling </offsets><italic><offsets xml_i="10661" xml_f="10666" txt_i="7008" txt_f="7013">et al</offsets></italic><offsets xml_i="10675" xml_f="10677" txt_i="7013" txt_f="7015"> [</offsets><xref ref-type="bibr" rid="B7"><offsets xml_i="10708" xml_f="10709" txt_i="7015" txt_f="7016">7</offsets></xref><offsets xml_i="10716" xml_f="10752" txt_i="7016" txt_f="7052">], the inclusion criterion was a PaO</offsets><sub><offsets xml_i="10757" xml_f="10758" txt_i="7052" txt_f="7053">2</offsets></sub><offsets xml_i="10764" xml_f="10768" txt_i="7053" txt_f="7057">/FiO</offsets><sub><offsets xml_i="10773" xml_f="10774" txt_i="7057" txt_f="7058">2</offsets></sub><offsets xml_i="10780" xml_f="11154" txt_i="7058" txt_f="7426"> ratio  &lt; 150, whereas  &lt; 300 was used in our study. However, two of our patients failed the assigned VC mode, while no patient on PRVC failed (P = 0.24). For this tendency to have achieved statistical significance, 110 patients should have been enrolled in the study. The risk of type 2 error for an overlooked difference of 10% failing VC is only 20% with 1-β = 80%.</offsets></p><p><offsets xml_i="11161" xml_f="11374" txt_i="7427" txt_f="7640">Further studies are needed to decide if PRVC improves outcome when compared with VC in patients with acute respiratory failure. Other subgroups, such as acute severe asthma or ARDS, could be a focus for attention.</offsets></p><p><offsets xml_i="11381" xml_f="11501" txt_i="7641" txt_f="7761">A recent review recommends pressure-control ventilation in all clinical circumstances requiring artificial ventilation [</offsets><xref ref-type="bibr" rid="B10"><offsets xml_i="11533" xml_f="11535" txt_i="7761" txt_f="7763">10</offsets></xref><offsets xml_i="11542" xml_f="12296" txt_i="7763" txt_f="8517">]. During PRVC, as with pressure control, there is a maximum pressure difference between the ventilator and the lung at the beginning of the inspiratory cycle. The resulting flow is also maximal. With the increase in intrathoracic pressure this difference diminishes, as does the resulting inspiratory flow. The flow pattern is therefore called decelerating inspiratory flow. In VC ventilation, there is a constant inspiratory flow and the resulting intrathoracic pressure is always increasing. Pressure-regulated ventilation is therefore capable of delivering the same volume at a lower PIP. This fact may play a more significant role when higher tidal volumes are required, and greater differences in peak pressures between PRVC and VC may be expected.</offsets></p><p><offsets xml_i="12303" xml_f="12489" txt_i="8518" txt_f="8704">Our conclusion is that, during mechanical ventilation for acute respiratory failure, PIP was significantly lower on PRVC than VC, and thus PRVC may be superior to VC in certain patients.</offsets></p><p><offsets xml_i="12496" xml_f="12672" txt_i="8705" txt_f="8881">Our results emphasize one of the basic problems in intensive care research-that therapeutic signals are too weak to be discovered in clinical trials consisting of few patients.</offsets></p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slustsky</surname><given-names>AS</given-names></name></person-group><article-title>ACCP consensus conference; mechanical ventilation.</article-title><source>Chest</source><year>1993</year><volume>104</volume><fpage>1833</fpage><lpage>1859</lpage><pub-id pub-id-type="pmid">8252973</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Webb</surname><given-names>HH</given-names></name><name><surname>Tierney</surname><given-names>DF</given-names></name></person-group><article-title>Experimental pulmonary oedema due to intermittent positive pressure ventilation with high inflation pressures. Protection by positive end-expiratory pressure.</article-title><source>Am Rev Respir Dis</source><year>1974</year><volume>199</volume><fpage>556</fpage><lpage>565</lpage></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corbridge</surname><given-names>TC</given-names></name><name><surname>Wood</surname><given-names>LD</given-names></name><name><surname>Crawford</surname><given-names>GP</given-names></name><name><surname>Chudoba</surname><given-names>JR</given-names></name><name><surname>Yanes</surname><given-names>J</given-names></name><name><surname>Sznaider</surname><given-names>JL</given-names></name></person-group><article-title>Adverse effects of large tidal volume and low PEEP in canin acid aspiration.</article-title><source>Am Rev Respir Dis</source><year>1990</year><volume>142</volume><fpage>311</fpage><lpage>315</lpage><pub-id pub-id-type="pmid">2200314</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mascheroni</surname><given-names>D</given-names></name><name><surname>Kolobov</surname><given-names>T</given-names></name><name><surname>Fumagalli</surname><given-names>R</given-names></name><etal></etal></person-group><article-title> Acute respiratory failure following pharmacologically-induced hyperventilation: an experimental animal study.</article-title><source>Intensive Care Med</source><year>1987</year><volume>15</volume><fpage>8</fpage><lpage>14</lpage></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beale</surname><given-names>R</given-names></name><name><surname>Grover</surname><given-names>ER</given-names></name><name><surname>Smithies</surname><given-names>M</given-names></name><name><surname>Bihari</surname><given-names>D</given-names></name></person-group><article-title>Acute respiratory distress syndrome (`ARDS'): no more than a severe acute lung injury?</article-title><source>Br Med J</source><year>1993</year><volume>307</volume><fpage>1335</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">8166803</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gattinoni</surname><given-names>L</given-names></name><name><surname>D'Andrea</surname><given-names>L</given-names></name><name><surname>Pelosi</surname><given-names>P</given-names></name><name><surname>Vitale</surname><given-names>G</given-names></name><name><surname>Pesenti</surname><given-names>A</given-names></name><name><surname>Fumagalli</surname><given-names>R</given-names></name></person-group><article-title> Regional effects and mechanism of positive end-expiratory pressure in early adult respiratory distress syndrome.</article-title><source> JAMA</source><year>1993</year><volume>269</volume><fpage>2122</fpage><lpage>2127</lpage><pub-id pub-id-type="pmid">8468768</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickling</surname><given-names>KG</given-names></name><name><surname>Walsh</surname><given-names>J</given-names></name><name><surname>Henderson</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>R</given-names></name></person-group><article-title> Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study.</article-title><source>Crit Care Med</source><year>1994</year><volume>22</volume><fpage>1568</fpage><lpage>1578</lpage><pub-id pub-id-type="pmid">7924367</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>MBP</given-names></name><name><surname>Barbas</surname><given-names>CSV</given-names></name><name><surname>Mediros</surname><given-names>DM</given-names></name><etal></etal></person-group><article-title>Beneficial effects of  `the open lung approach' with low distending pressures in ARDS.</article-title><source>Am J Respir Crit Care Med</source><year>1995</year><volume> 152</volume><fpage>1835</fpage><lpage>1846</lpage><pub-id pub-id-type="pmid">8520744</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rappaport</surname><given-names>SH</given-names></name><name><surname>Shpiner</surname><given-names>R</given-names></name><name><surname>Yoshihara</surname><given-names>G</given-names></name><name><surname>Wright</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure.</article-title><source>Crit Care Med</source><year>1994</year><volume>22</volume><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">8124968</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Böhm</surname><given-names>S</given-names></name><name><surname>Lachmann</surname><given-names>B</given-names></name></person-group><article-title>Pressure-control ventilation. Putting a mode into perspective.</article-title><source> J Intensive Care</source><year>1996</year><volume>3</volume><fpage>12</fpage><lpage>27</lpage></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Physiological variables during the two modes of mechanical ventilation, pressure-regulated pressure control (PRVC) and volumne control (VC)</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="left">PRVC (<italic>n</italic> = 44)</td><td align="left">VC (<italic>n</italic> = 44)</td><td align="center"><italic>P</italic></td></tr></thead><tbody><tr><td align="left">PIP (cmH<sub>2</sub>O)</td><td align="left">20 (19-23)</td><td align="left">24 (23-27)</td><td align="center"> &lt; 0.0001</td></tr><tr><td align="left">MAIP (cmH<sub>2</sub>O)</td><td align="left">10 (9-11)</td><td align="left">10 (9-11)</td><td align="center">ns</td></tr><tr><td align="left">PaO<sub>2</sub> (mmHg)</td><td align="left">98 (93-111)</td><td align="left">96 (92-108)</td><td align="center">ns</td></tr><tr><td align="left">PaCO<sub>2</sub> (mmHg)</td><td align="left">43 (40-46)</td><td align="left">43 (40-46)</td><td align="center">ns</td></tr><tr><td align="left">pH</td><td align="left">7.38 (7.11-7.65)</td><td align="left">7.38 (7.10-7.65)</td><td align="center">ns</td></tr><tr><td align="left">MAP (mmHg)</td><td align="left">76 (73-83)</td><td align="left">77 (74-84)</td><td align="center">ns</td></tr></tbody></table><table-wrap-foot><p>Values are means (95% confidence limits). PIP = peak inspiratory pressure; MAIP = mean airway pressure; PaO<sub>2</sub> = partial pressure of arterial oxygen; PaCO<sub>2</sub> = partial pressure of arterial carbon oxide; MAP = mean arterial blood pressure.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Results of the general trial</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">PRVC (<italic>n</italic> = 22)</td><td align="center">VC (<italic>n</italic> = 22)</td><td align="center"><italic>P</italic></td></tr></thead><tbody><tr><td align="left">Days on ventilator</td><td align="center">7.0 (3.8-10.3)</td><td align="center">6.2 (3.8-8.5)</td><td align="center">ns</td></tr><tr><td align="left">Failing</td><td align="center">0/22</td><td align="center">2/22</td><td align="center">ns</td></tr><tr><td align="left">Survival</td><td align="center">12/22</td><td align="center">11/22</td><td align="center">ns</td></tr></tbody></table><table-wrap-foot><p>Days on ventilator = median (95% confidence limits) number of days spent on mechanical ventilation; Failing = number of patients failing the assigned mode of ventilation; Survival = survival in the two groups.</p></table-wrap-foot></table-wrap></sec></back></article>